Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.
暂无分享,去创建一个
M. Dougados | A. Calin | I. Olivieri | D. M. van der Heijde | D. Heijde | H. Zeidler | H. Herman | J. Béhier | I. Jolchine | D. V. D. Heijde | Jéhan-Michel Béhier | Hélène Herman | D. Heijde